Equine odontoclastic tooth resorption and hypercementosis: Who does it affect and how do we manage it? (Proceedings PDF)

Medicus Pharma submitted a product development plan to the FDA for an Investigational New Animal Drug designation.

Alex Sigmund, DVM, DACVO, shares his expertise on dealing with ocular emergencies on this episode of The Vet Blast Podcast presented by dvm360.

As equine veterinarians and advocates work to ensure their patient-athletes are receiving proper care, scientists work to advance therapies and better understand their physiology

Drs Adam Christman and Christopher Byers highlight recent FIP treatment advancements

This skeletal muscle infection is best managed in a hospital

The new guidelines will address 2 viral causes of liver damage impact equine patients